Rosai-Dorfman disease following bone marrow transplantation for pre-B cell acute lymphoblastic leukemia

Pediatr Blood Cancer. 2008 Sep;51(3):433-5. doi: 10.1002/pbc.21606.

Abstract

A child with acute pre-B cell lymphoblastic leukemia underwent haploidentical bone marrow transplantation (BMT) after first relapse. Approximately 8 months after the BMT, he developed a soft tissue mass overlying a defect in the left frontal bone. He was found to have several additional osteolytic lesions but no evidence of lymphadenopathy or organomegaly. A biopsy of the presenting lesion demonstrated a polymorphous infiltrate composed predominantly of S-100 protein and CD68 immunoreactive histiocytic cells. Together with the presence of emperipolesis, the process was interpreted as Rosai-Dorfman (R-D) disease. He received chemotherapy with vinblastine, prednisone, 6-mercaptopurine and methotrexate and has been in remission for over 4 years. Only one previous example of acute lymphoblastic leukemia in childhood has been reported with R-D disease.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation / adverse effects*
  • Fatal Outcome
  • Graft vs Host Disease / etiology*
  • Histiocytes
  • Histiocytosis, Sinus / etiology*
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Remission Induction
  • S100 Proteins

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • S100 Proteins